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Background: Gastric outlet obstruction (GOO) is characterized by persistent non-bilious 
vomiting due to obstruction at the pylorus. GOO is associated with Helicobacter pylori 
through both malignant and benign processes. The objective of this study was to determine 
the epidemiology of gastric outlet obstruction in Rwanda. 
Methods: A cross-sectional descriptive study was undertaken on patients with GOO seen 
over a 12-month period. Patients’ demographics, histopathology, H.pylori infection and 
mortality, were analyzed using Chi-square (χ2) test and logistic regression. Mortality was 
assessed with a minimum follow up of 3 months. 
Results: A total of 82 patients presenting with GOO were studied. The rate of 
H.pyloriinfection was 61%. Malignant histopathology was found in 67% of patients. 
Bivariate analysis showed that pylori infection was associated with a benign 
histopathology (X2 =4.77, p=0.029). Logistic regression showed that malignant 
histopathology was associated with decreased survival (Odds Ratio = 0.072, 95% 
Confidence Interval = 0.018-0.289, p< 0.001). There was no statistically significant 
difference in mortality between surgical and non-surgical patients with malignant 
histopathology (X2=1.41, p= 0.495). 
Conclusions: Malignancy is a common cause of GOO in Rwanda and is associated with 
increased mortality whether treated surgically or non-surgically. Over 50% of patients 
with GOO in Rwanda were infected with H pylori. 
Introduction 
Gastric outlet obstruction (GOO) describes a clinical condition represented by any disease 
process causing mechanical obstruction to gastric emptying, including both benign or malignant 
conditions1.The incidence of GOO is not precisely known but in developed countries it has been 
estimated at 5% among patients with benign conditions and in peripancreatic malignancy it has 
been reported at 15-20%2. GOO in developed countries is predominantly associated with 
malignancy3. However, in developing countries such as Ethiopia, the majority of studies report a 
benign aetiology4. Helicobacter pylori infect the stomach and produce an inflammation that may 
contribute to complete or incomplete obstruction of the distal stomach, pylorus or proximal 
duodenum5. The prevalence of H. pylori infection among patients with GOO in developed 
countries is approximately 69%6.  In Rwanda the prevalence of H.pylori among patients 
undergoing endoscopy was 75%7. 
 
The majority of patients with GOO often seek medical care late when the patient is dehydrated 
and nutritional status is compromised(4). A study conducted in Netherlandson patients with 
advanced malignant GOO reported a post-operative mortality rate of 95%(8). GOO in Rwanda is 
a common medical condition. However, the causes of GOO and short-term outcomes of surgery 
have not been adequately studied. Further information is needed to address this public health 
The aim of this study was to identify the etiology of GOO, the rate of H.pylori infection in patients 
with GOO and the short-term outcomes for those undergoing surgery at the University Teaching 
Hospitals of Kigali and Butare. 
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Patients and Methods 
This was a descriptive cross-sectional study involving patients with a clinical diagnosis of GOO 
conducted at the University Teaching Hospitals of Kigali and Butare over a twelve-month period 
(April 2013 to March 2014). All patients with a diagnosis of GOO confirmed by endoscopy or 
laparotomy were included. Pediatric patients (<15 years old) and those without biopsy results 
were excluded from the study. The University Teaching Hospitals of Kigali (CHUK) and Butare 
(CHUB) are national referral and teaching hospitals in Rwanda. CHUK has a bed capacity of 586 
with a catchment area of more than 11 million people. CHUB has a bed capacity of 329 and a 
catchment area of more than 2 million people. 
 A trained physician performed all endoscopic procedures. GOO was suggested by the inability 
to progress the endoscope through the pylorus or intubate the duodenal bulb. For patients who 
underwent laparotomy, the diagnosis of GOO was made by the surgeon noting a protruding 
mass in the antrum, a cicatrized first part of duodenum, or a pylorus with a dilated and thick-
walled stomach. To identify the underlying cause of GOO two biopsies were taken from the 
antral mass and two more away from the lesion. Biopsy specimens were immediately fixed in 
20% formalin and sent for histopathological analysis. Specimens were analyzed at the King 
Faisal Hospital, University of Rwanda Pharmaceutical Research Laboratories in Rwanda and/or 
and the Brigham and Women’s Hospital USA.  
H.pylori infection was diagnosed immediately at endoscopy by performing a modified rapid 
urease test (MRUT) to fresh biopsies taken from the mucosa of the stomach, distant from the 
antral mass. The MRUT test materials were freshly made following the description of Katelaris 
et al, who found a test sensitivity of 97% and specificity of 95%(9). After endoscopy, patients 
were either placed on the theatre waiting list or underwent immediate laparotomy.  
The choice of surgical procedure was at the discretion of the operating surgeon. The most 
common surgical procedure was gastrojejunostomy with one patient undergoing antrectomy 
and gastrojejunostomy (Billroth II).All patients were telephoned at least once per month for a 
minimum of three months for follow up and document the patient’s status. 
Statistical analysis was performed using the Statistical Package for Social Sciences (SPSS) 
version 16.0 for Windows. Frequencies and percentages were reported for categorical variables. 
Age was evaluated as a categorical variable. Factors associated with benign or malignant 
etiologies of GOO were assessed using the Chi-squared test. Bivariate analysis of factors 
associated with mortality was performed using the Chi-squared test. A p value <0.05 was 
considered to be statistically significant. For those patients who survived, data from the date of 
last contact was used.  
 
Ethical approval was obtained from the School of Medicine, College of Medicine and Health 
Sciences at the University of Rwanda as well as from the Ethical Review Board at the University 
Teaching Hospital of Kigali. Informed consent was obtained from all patients or the witness of 
patients enrolled in the study. 
Results 
Eighty-two (82) patients were diagnosed with GOO. The majority (76%) were farmers. 54 
(66%) patients were older than 50 years of age and 58% were male (Table 1). 50% completed 
primary school education. Most patients (98.8%) reported epigastric pain, intermittent non–
bilious postprandial vomiting, and weight loss. The mean duration of epigastric pain was 27.5 
months (SD: 36.8).Sixty-seven percent (67%) of patients reported using a combination of 
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Table 1. Characteristics of patients presenting with gastric outlet obstruction 
 Frequency Percentage 
Demographics 
Age  
<50 years 28 34.1 
>50 years 54 65.9 
Gender  
Male 48 58.5 
Female 34 41.5 
Aetiology  
Malignant 55 67.1 
Intestine 48 58.5 
Diffuse 7 8.5 
Benign 27 32.9 
Chronic gastritis 21 25.6 
Erosive gastritis 3 3.7 
Other  3 3.6 
H. pylori 
Positive 50 60.9 
Negative 32 39.1 
Management  
Non operative 47 57.3 
Benign 15 18.3 
Malignancy 32 39.0 
Surgery 35 42.7 
Benign 12 14.6 
Malignancy 23 28.0 
 Outcomes  
Survival 41 55.4 
Mortality 33 44.6 
 
Table 2. Factors associated with etiology of GOO 
 Benign Malignant X2 P value 
Age 
<50 years 12 (14.7%) 17 (20.7%) 1.89 0.168 
>50 years 15 (18.3%) 38 (46.3%)   
Gender 
Male 18 (21.9%) 30 (36.5%) 1.09 0.295 
Female 9 (10.9%) 25 (30.5%)   
H.pylori 
Positive 21 (25.6%) 29 (35.4%) 4.77 0.029 
Negative 6 (7.3%) 26 (31.7%)   
 
Overall, 55(67.1%) cases of GOO were associated with malignancy, while 27(32.9%) cases had a 
benign etiology. Chronic gastritis was the most common diagnosis in benign disease, accounting 
for 21(25.6%) cases of GOO. Intestinal type accounted for the most common malignant etiology 
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with 48(58.5%) cases of GOO. H.pylori was detected in 50 (61%) patients. Bivariate analysis 
showed H.pylori infection to be significantly associated with a benign etiology of GOO (χ2 =4.77, 
p=0.029) (Table2). 
 
A total of 35 (43%) patients underwent surgical treatment for GOO. Of these, 23 (66%) had a 
malignant etiology while the remainder were benign. Most patients (97%) underwent 
gastrojejunostomy with only one patient undergoing antrectomy and gastrojejunostomy     
(Billroth II). 
 
Table 3. Outcomes and relationship to epidemiologic and clinical characteristics 
 Survival Mortality OR 95% CI P value 
Age  
< 50 years 19 (25.6%) 8 (10.8%) 2.633 0.833-8.318 0.050 
> 50 years 22 (29.7) 25 (33.7%) 
Gender  
Male 23 (31.1%) 19 (25.6%) 0.94 0.34-2.64 0.898 
Female 18 (24.3) 14 (18.9)   
Aetiology 
Malignant 17 (20.2%) 30 (49.5%) 0.072 0.018-0.279 <0.001 
Benign 24 (32.4%) 3 (3.85%) 
Management  
Non operative 23 (31.1%) 16 (21.6%) 1.36 0.49-3.78 0.495 
Surgery 18 (24.3%) 17 (22.9%)   
 
A follow up period of at least three months was possible in 74 of 82 (90%) patients with GOO. 
The eight patients (10%) lost to follow up all had malignant disease. The overall mortality rate 
at three months of follow up was 44.5% (Table 1).Bivariate analysis showed that age greater 
than 50 years (χ2=3.85, p= 0.050) and malignant etiology of disease (χ2= 19.29, p<0.001) were 
associated with increased mortality. Multivariate logistic regression revealed that a malignant 
aetiology of GOO was associated with decreased survival compared to benign causes (OR= 
0.072, 95%CI=0.018-0.279, p<0.001) (Table 3).In patients with malignancy, the 3-month 
survival was not statistically different between those operated on and those not (χ2=1.41, 
p=0.495) (Table 3). 
Discussion 
GOO is a common surgical problem in Rwanda and poses many challenges to the general 
surgeon. A recent study in Rwanda of 961endoscopies found the prevalence of GOO to be 
relatively high at 10%, compared with other settings7. The current study was conducted to 
identify common etiologies of GOO, the rate of H.pylori infection in patients with GOO and the 
short-term outcomes for those undergoing surgery. To date, these problems have not been 
adequately studied in Rwanda. 
Two thirds of patients were found to have a malignant etiology of GOO. This finding is similar to 
other studies in developing countries such as Tanzania, Pakistan and India10, 11, 12. It contrasts 
with studies in Nigeria and Ethiopia13, 14. Rwanda is situated in the Great Lakes region of Africa 
where the incidence of gastric cancer is high (3.2 per 100,000) and previous studies have shown 
that Rwanda has a high incidence of gastric cancer (13 to 15 per 100,000)14.In developed 
countries, the predominance of malignancy is theorized to be due to a declining rate of benign 
etiologies secondary to the early identification and treatment of H.pylori and the use of proton 
66 
66 
ISSN 2073-9990   East Cent. Afr. J. surg 
 
COSECSA/ASEA Publication    -East and Central African Journal of Surgery.  July/August 2015 Volume 20 (2)       
 
pump inhibitors3. However, it is unknown whether the same principle applies in sub-Saharan 
Africa. 
Of malignant specimens in our study, 87% showed intestinal type disease. This type has been 
frequently identified in distal gastric biopsies and in populations at high risk for gastric cancer15. 
Similar findings of intestinal type were predominant (62.9%) in a study conducted in Japan16. In 
Uganda, intestinal metaplasia was observed in the majority of Nyarwanda and Nkole tribes17.  In 
contrast, in China a study examining the biopsies of gastric carcinoma revealed 47.8% of 
patients had diffuse-type18. The increased rate of intestine -type disease found in Rwanda could 
be attributed to the high rate of H. pylori infection (61%), which is a known risk factor. A meta-
analysis conducted in Japan reported that each year, 5% of H.pylori positive patients develop 
gastric cancer19. 
In this study, the prevalence of H. pylori among patients with GOO was 61%. Previous 
endoscopic studies conducted in Rwanda showed a prevalence of H.pylori of 75% in all patients 
(9, 20). In developed countries the variation in prevalence of H.pylori infection among patients 
with GOO ranges from 33 to 69%6, 21. The disparity in prevalence rates could be related to 
variations in the sensitivity of the test used and the underlying cause of GOO. Kate et al found 
the prevalence of H.pylori to be 91% after using multiple testing including serology, histology 
and rapid urease test among patients with GOO and active ulcers in the duodenum22. Our 
findings are similar to previous data reported in Rwanda and confirm prior reports that H. 
pylori infection is significantly associated with benign etiology of GOO23.  
 
There was no statistically significant association between malignant etiology of GOO and 
H.pylori infection. H.pylori is one of many independent factors in gastric carcinogenesis which 
has been reported in several case-control studies24.Others factors such as genetic, dietary, and 
environmental factors play a major role in development of gastric malignancy among patients 
with negative H.pylori testing25. Many of these independent factors were not evaluated in this 
study. 
The lack of statistical difference between H.pylori infection and malignant aetiology of GOO 
could be due to prior medical treatment. H pylori infection may also be underestimated because 
of the laboratory methods used to diagnose H.pylori. By combining immunohistologic biopsy 
specimens with antibodies against H.pylori, some studies have detected a prevalence of H.pylori 
in gastric cancer of 98%26. 
In this study, the highest frequency of patients with GOO was in the group age over 50 years. 
Similar results were reported by Kotisso in Ethiopia4. A retrospective study conducted on 
patients with GOO in developed countries reported a mean age of 61 years10. Additionally the 
majority of deaths (75%) occurred in patients aged greater than50 years. Bivariate analysis 
revealed that independent factors for mortality were age greater than 50 years and malignancy. 
Jaka et al10 found that patients age greater than 60 years and malignant causes of GOO were 
significantly associated with higher mortality rates10. However, on multivariate analysis 
malignancy alone was associated with mortality. The high mortality in our setting may be due to 
delayed patient presentation. Most patients had a mean duration of symptoms of 27.5 months 
(SD=36.8 months) prior to evaluation at a referral hospital. Patients may delay at home while 
receiving treatment and medicines from traditional healers. There may also be delays within the 
healthcare system resulting in delayed referral to a tertiary hospital.  
This study has several limitations. Many investigations were not routinely available due to 
financial constraints. The stage of malignancy at time of presentation influences overall 
mortality results as well as the choice of operation. Also, many patients do not routinely see a 
physician, so there is limited data on co-morbidities, which could influence mortality. Further 
studies would be needed to include these factors in the analysis. Despite these limitations, the 
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study provides local data that can be used by health care providers to plan for preventive 
strategies as well as institute management guidelines for these patients. 
Conclusion 
GOO is a common surgical problem in our setting with malignancy accounting for the majority 
of cases. Malignant etiology was associated with increased mortality but the mortality rate was 
similar in surgical and non-surgical patients. H.pylori infection is associated with a benign 
etiology of GOO. Providers at the health center and district hospital should be educated about 
GOO and refer patients early to optimize outcomes. 
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